CoChat

Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Objective: Glucocorticoid (GC) therapy is associated with adverse effects on bone metabolism, yet the effects of different GC physiological replacement regimens in hypopituitarism are not well characterised. We aimed to assess the effect of three hydrocortisone (HC) replacement dose regimens on bone turnover. Study design: An open cross-over study randomising ten hypopituitary men with severe ACTH deficiency to three commonly used HC dose regimens: dose A (20 mg mane and 10 mg tarde), dose B (10 mg mane and 10 mg tarde) and dose C (10 mg mane and 5 mg tarde). Methods: Following 6 weeks of each regimen, the participants underwent 24-h serum cortisol sampling and measurement of bone turnover markers: bone-specific alkaline phosphatase, procollagen type I N-propeptide (PINP), intact osteocalcin (OC(1–49)), C-terminal cross-linking telopeptide (CTX-I) and tartrate-resistant acid phosphatase 5b (TRACP5b). Bone remodelling balance was estimated as an absolute ratio (PINP:CTX-I) and as an index using standardised scores derived from the matched controls. Results: There were significant increases in the concentrations of the formation markers PINP (P=0.045) and OC(1–49) (P=0.006) and in the PINP:CTX-I ratio (P=0.015), and a more positive bone remodelling balance index (P=0.03) was observed in patients on the lowest dose C than in those on the highest dose A. Mean 24-h cortisol concentrations correlated negatively with CTX-I (r=−0.66 and P=0.04) and TRACP5b (r=−0.74 and P=0.01) in patients on dose B and with OC(1–49) (r=−0.66 and P=0.04) and CTX-I (r=−0.81 and P<0.01) in patients on dose C. In patients receiving the lower-dose regimen, trough cortisol concentrations correlated with increased bone formation and resorption. Conclusion: Low-dose HC replacement (10 mg mane and 5 mg tarde) is associated with increased bone formation and a positive bone remodelling balance. This may have a long-term beneficial effect on bone health.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-13-0596

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 4

  1. McDougall, 1994, The Journal of Rheumatology, 21, 1207
  2. 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 20, 1487
  3. Verrotti, 2000, Annals of neurology, 47, 385, 10.1002/1531-8249(200003)47:3<385::aid-ana18>3.0.co;2-w · doi:10.1002/1531-8249(200003)47:3<385::aid-ana18>3.0.co;2-w
  4. 2005, CLINICAL BIOCHEMIST REVIEWS, 26, 97

Cited by

See all 23

Metadata

Authors
Behan, L.-A., Kelleher, G., Hannon, M. J., Brady, J. J., Rogers, B., Tormey, W., Smith, D., Thompson, C. J., McKenna, M. J., & Agha, A.
Affiliations
  • Beaumont Hospital (IE)
  • St. Vincent's University Hospital (IE)
  • University College Dublin (IE)
Corresponding author
Agha, Amar
Venue
European Journal of Endocrinology
Published
2014-01
Volume
170
Issue
1
Pages
141-150
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2142225547
Cited by
23
References
36
Citations by year
2026: 1 · 2024: 3 · 2022: 3 · 2021: 3 · 2020: 3 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 1
FWCI
2.04
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Royal College of Surgeons in Ireland
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
hydrocortisone replacement, hypopituitarism, ACTH deficiency, bone turnover markers, bone formation, bone resorption, bone-specific alkaline phosphatase, P1NP, osteocalcin, C-terminal telopeptide of type I collagen, TRACP-5b, male patients, bone health
MeSH terms
Adrenal Insufficiency, Adult, Bone and Bones, Bone Resorption, Dose-Response Relationship, Drug, Glucocorticoids, Humans, Hydrocortisone, Hypopituitarism, Male, Middle Aged, Osteogenesis, Severity of Illness Index, Cohort Studies, Biomarkers, Bone Remodeling, Cross-Over Studies, Hormone Replacement Therapy, Bone Density Conservation Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients. https://app.cochat.ai/papers/10.1530/eje-13-0596
The paper
Behan, L.-A., Kelleher, G., Hannon, M. J., Brady, J. J., Rogers, B., Tormey, W., Smith, D., Thompson, C. J., McKenna, M. J., & Agha, A. (2014). Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients. European Journal of Endocrinology. https://doi.org/10.1530/eje-13-0596

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.